{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"l-2-hydroxyglutaric-aciduria","columns":[{"gene":"","key":"population-5c65c2a5e4e46705b119","label":"L-2-hydroxyglutaric aciduria","mondoId":"MONDO:0009370","onsetQualifier":null,"originColumnKey":"MONDO:0009370/OMIM:236792","originalViews":[{"key":"MONDO:0009370/OMIM:236792","label":"L-2-hydroxyglutaric aciduria","scopeLabel":"OMIM:236792","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["03129a57a9d805ca6ac3f18b5b4662ce03afeff566fbcbfc80864a442db568da","25d7c036813c118993c3884fd9f268c333e8a8088ac78277c72f68e0cebcb5b7","2eb3dfbfe9c0f7b33dbd7c679f4dca0dc07d1bf0d808d82802a5184c7e81380f","3e843cb720f21dd7ac1a02c3603d232bab3357f0f8988da137d84adea132ce0f","620f41bacdf6e426528fd0433db68c6d4490a7cefbf835a2f71f615bae12ae0c","66d0e34b76559707dfd9dfcead92c4c69eaebfccd91b93c872e121e028798d8b","6f5f6cda22856c01d0145709eb34e0beb0577188d5531e9b6fdf8a5cd5af9563","71f23a9d469ac9f0d8fbd9f1aa2a12c2b8e0fa033d576f0c056c44122a4f8ce5","7364f15c5f9842cbe02732b833d1d504237080dc66feb74e295a366191b5d8f1","7440695422fa4e83cf11b2a287cea26b466f18e4d2771b8b06376fae63b7dd35","79d79c48b685e27c1ef33d242a5bda3e68227c8e74624822d609024c4148523b","85120a2404a5d3da647b14407c7a516c600cbaabec4241b770ae889543012654","8c90b55c0a964412c6642bafd330cd59978abe011b71e098a61a737105314dc3","8d6d2ff8b17f37a06ce986e25079cd06cf4daffa2254a505dcc1e340b9009dbe","997a8031e666b68daa8729e243d5e1033733620b8bc9173eaa00394072bba983","a4875883b11404393aff6b23c36515a667e5de83823b38cab672d143d2cfb083","c398a1af037b704140551e16a11b5262f8377b19dd88803e58efce83825d2575","d8deb182f22ba5085c8a9b0878ca7683957c047f044c08da600b39da8122d823","dbfbbb1710d4bae07c44bd5d1ae789b28c43a908c09840ef1745ddcab5d29c74","f1f6fe290c472d8f8b89c9b021bb04ead1c9e454def7f8145e00db75a79558d2","fe5e32aa129bb3a182e4d789e1bc8d46267b917bc2d65e967549b94775a067e4"],"recordQualifiers":{},"scopeLabel":"OMIM:236792","sourceIds":["OMIM:236792"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-a789de5440e628724ae5","label":"L-2-hydroxyglutaric aciduria","mondoId":"MONDO:0009370","onsetQualifier":null,"originColumnKey":"MONDO:0009370/ORPHA:79314","originalViews":[{"key":"MONDO:0009370/ORPHA:79314","label":"L-2-hydroxyglutaric aciduria","scopeLabel":"ORPHA:79314","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["08ef852b4e121fe7fd30756233001a83fc107624638b64255750ab816cd1490c","0e9048ef71ad29777d742a2229dffe3d0158c639bd4b3d8b88aef24c1c826454","31696a64f0abac92680665e19df7a73f65eefebc2f50ad3610018035eaa10939","3a9d3529df57a02548f5704962b90498fdd204d16eeeede76d0b6ba4d38f7bbf","3b2015c15b1b3f82e261a58c5302091f65b5cedf7de08febc1d6ac8c0492fb57","4066dd0eae3767729ca7bb5d2d7665f96a88e08d6d0cb0702e5e0af240a55ab8","6e602cc871f4279522bafcea3ba4dd19334dd2da0666f6cb3d6ba4ab63384535","85fb288b1d09f8d1e826b92efc95b8e20c9262bed6e39a71cb27fd9ff8932b4d","a06c9e761a8ca444f0bddc696f73f85d8fae621e0f4f82db05c08af2003cfa95","a3a1b4fe9cee64d70dc8a0314217fa922b654332a3ad079f8f8f3545e76a6ece","d2e5ecac582ee6747739ffc064421f26283dd943fca3c1706b29809ddb7974c0","dec8425d78b12f581ade7945f3cc4ba4ec02b43c90c7f53493e525c1d0730465"],"recordQualifiers":{},"scopeLabel":"ORPHA:79314","sourceIds":["ORPHA:79314"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-5c65c2a5e4e46705b119","population-a789de5440e628724ae5"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0007256","HP:0002062","HP:0002071","HP:0002381","HP:0007360","HP:0001251","HP:0000708"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":33,"sourceGroups":{"omim":16,"orphanet":12,"published":5}},"features":[{"hpoId":"HP:0007256","label":"Abnormal pyramidal sign","primary":true},{"hpoId":"HP:0002062","label":"Abnormal pyramidal tract morphology","primary":true},{"hpoId":"HP:0002071","label":"Abnormality of extrapyramidal motor function","primary":true},{"hpoId":"HP:0002381","label":"Aphasia","primary":true},{"hpoId":"HP:0007360","label":"Aplasia/Hypoplasia of the cerebellum","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0000708","label":"Atypical behavior","primary":true},{"hpoId":"HP:0001272","label":"Cerebellar atrophy","primary":false},{"hpoId":"HP:0007371","label":"Corpus callosum atrophy","primary":false},{"hpoId":"HP:0002376","label":"Developmental regression","primary":false},{"hpoId":"HP:0002171","label":"Gliosis","primary":false},{"hpoId":"HP:0002283","label":"Global brain atrophy","primary":false},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0002383","label":"Infectious encephalitis","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0040147","label":"L-2-hydroxyglutaric acidemia","primary":false},{"hpoId":"HP:0040144","label":"L-2-hydroxyglutaric aciduria","primary":false},{"hpoId":"HP:0002352","label":"Leukoencephalopathy","primary":false},{"hpoId":"HP:0000256","label":"Macrocephaly","primary":false},{"hpoId":"HP:0004375","label":"Neoplasm of the nervous system","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0007258","label":"Severe demyelination of the white matter","primary":false},{"hpoId":"HP:0010864","label":"Severe intellectual disability","primary":false},{"hpoId":"HP:0001285","label":"Spastic tetraparesis","primary":false},{"hpoId":"HP:0000486","label":"Strabismus","primary":false}],"ledeHtml":"L-2-hydroxyglutaric aciduria is an inherited metabolic condition that is associated with progressive brain damage. Signs and symptoms of this condition typically begin during infancy or early childhood and may include developmental delay, seizures, speech difficulties, macrocephaly and abnormalities in a part of the brain called the cerebellum, which is involved in coordinating movement (i.e. balance and muscle coordination). L-2-hydroxyglutaric aciduria is caused by changes in the L2HGDH gene and is inherited in an autosomal recessive manner.","mondoId":"MONDO:0009370","node":{"canonicalSlug":"l-2-hydroxyglutaric-aciduria","comparisons":[{"documentSha256":"b29370411275f295db7fdff6e555648ed24bbddfdeb5b5354f7ca9857af0dcfa","key":"legacy-2-hydroxyglutaric-aciduria","kind":"legacy","label":"2-hydroxyglutaric aciduria","memberIds":["MONDO:0009370","MONDO:0010924","MONDO:0013345","MONDO:0014072","MONDO:0016001","MONDO:0024554"],"mondoId":"MONDO:0016001","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/2-hydroxyglutaric-aciduria.b29370411275f295db7fdff6e555648ed24bbddfdeb5b5354f7ca9857af0dcfa.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"L-2-hydroxyglutaric aciduria","originalSourceId":"ORPHA:79314","paragraphs":["L-2-hydroxyglutaric aciduria is an inherited metabolic condition that is associated with progressive brain damage. Signs and symptoms of this condition typically begin during infancy or early childhood and may include developmental delay, seizures, speech difficulties, macrocephaly and abnormalities in a part of the brain called the cerebellum, which is involved in coordinating movement (i.e. balance and muscle coordination). L-2-hydroxyglutaric aciduria is caused by changes in the L2HGDH gene and is inherited in an autosomal recessive manner."],"rawAttribution":"MONDO:0009370","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:08Z","upstream":"GARD:0010472","url":"https://rarediseases.info.nih.gov/diseases/10472"},"ownColumnKeys":["population-5c65c2a5e4e46705b119","population-a789de5440e628724ae5"],"publication":"published","relationships":[{"kind":"parent","label":"2-hydroxyglutaric aciduria","mondoId":"MONDO:0016001","slug":"2-hydroxyglutaric-aciduria"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"03129a57a9d805ca6ac3f18b5b4662ce03afeff566fbcbfc80864a442db568da","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:15548604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"08ef852b4e121fe7fd30756233001a83fc107624638b64255750ab816cd1490c","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004375","is_excluded":false,"label":"Neoplasm of the nervous system","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0e9048ef71ad29777d742a2229dffe3d0158c639bd4b3d8b88aef24c1c826454","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"25d7c036813c118993c3884fd9f268c333e8a8088ac78277c72f68e0cebcb5b7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002071","is_excluded":false,"label":"Abnormality of extrapyramidal motor function","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"2eb3dfbfe9c0f7b33dbd7c679f4dca0dc07d1bf0d808d82802a5184c7e81380f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002283","is_excluded":false,"label":"Global brain atrophy","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"31696a64f0abac92680665e19df7a73f65eefebc2f50ad3610018035eaa10939","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002381","is_excluded":false,"label":"Aphasia","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3a9d3529df57a02548f5704962b90498fdd204d16eeeede76d0b6ba4d38f7bbf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3b2015c15b1b3f82e261a58c5302091f65b5cedf7de08febc1d6ac8c0492fb57","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002383","is_excluded":false,"label":"Infectious encephalitis","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3e843cb720f21dd7ac1a02c3603d232bab3357f0f8988da137d84adea132ce0f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"4066dd0eae3767729ca7bb5d2d7665f96a88e08d6d0cb0702e5e0af240a55ab8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"620f41bacdf6e426528fd0433db68c6d4490a7cefbf835a2f71f615bae12ae0c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007371","is_excluded":false,"label":"Corpus callosum atrophy","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"66d0e34b76559707dfd9dfcead92c4c69eaebfccd91b93c872e121e028798d8b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002171","is_excluded":false,"label":"Gliosis","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"6e602cc871f4279522bafcea3ba4dd19334dd2da0666f6cb3d6ba4ab63384535","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001285","is_excluded":false,"label":"Spastic tetraparesis","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"6f5f6cda22856c01d0145709eb34e0beb0577188d5531e9b6fdf8a5cd5af9563","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001285","is_excluded":false,"label":"Spastic tetraparesis","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"71f23a9d469ac9f0d8fbd9f1aa2a12c2b8e0fa033d576f0c056c44122a4f8ce5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"PMID:15548604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7364f15c5f9842cbe02732b833d1d504237080dc66feb74e295a366191b5d8f1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002062","is_excluded":false,"label":"Abnormal pyramidal tract morphology","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7440695422fa4e83cf11b2a287cea26b466f18e4d2771b8b06376fae63b7dd35","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"79d79c48b685e27c1ef33d242a5bda3e68227c8e74624822d609024c4148523b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0040147","is_excluded":false,"label":"L-2-hydroxyglutaric acidemia","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"85120a2404a5d3da647b14407c7a516c600cbaabec4241b770ae889543012654","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"85fb288b1d09f8d1e826b92efc95b8e20c9262bed6e39a71cb27fd9ff8932b4d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007360","is_excluded":false,"label":"Aplasia/Hypoplasia of the cerebellum","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"8c90b55c0a964412c6642bafd330cd59978abe011b71e098a61a737105314dc3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0002352","is_excluded":false,"label":"Leukoencephalopathy","onset_id":null,"reference":"PMID:15548604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8d6d2ff8b17f37a06ce986e25079cd06cf4daffa2254a505dcc1e340b9009dbe","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"997a8031e666b68daa8729e243d5e1033733620b8bc9173eaa00394072bba983","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"a06c9e761a8ca444f0bddc696f73f85d8fae621e0f4f82db05c08af2003cfa95","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000256","is_excluded":false,"label":"Macrocephaly","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a3a1b4fe9cee64d70dc8a0314217fa922b654332a3ad079f8f8f3545e76a6ece","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000708","is_excluded":false,"label":"Atypical behavior","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"a4875883b11404393aff6b23c36515a667e5de83823b38cab672d143d2cfb083","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"PMID:15548604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c398a1af037b704140551e16a11b5262f8377b19dd88803e58efce83825d2575","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000486","is_excluded":false,"label":"Strabismus","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d2e5ecac582ee6747739ffc064421f26283dd943fca3c1706b29809ddb7974c0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002071","is_excluded":false,"label":"Abnormality of extrapyramidal motor function","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"d8deb182f22ba5085c8a9b0878ca7683957c047f044c08da600b39da8122d823","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"dbfbbb1710d4bae07c44bd5d1ae789b28c43a908c09840ef1745ddcab5d29c74","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0040144","is_excluded":false,"label":"L-2-hydroxyglutaric aciduria","onset_id":null,"reference":"PMID:15548604","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"dec8425d78b12f581ade7945f3cc4ba4ec02b43c90c7f53493e525c1d0730465","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:79314","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010864","is_excluded":false,"label":"Severe intellectual disability","onset_id":null,"reference":"ORPHA:79314","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f1f6fe290c472d8f8b89c9b021bb04ead1c9e454def7f8145e00db75a79558d2","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002381","is_excluded":false,"label":"Aphasia","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"fe5e32aa129bb3a182e4d789e1bc8d46267b917bc2d65e967549b94775a067e4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:236792","disease_name":"L-2-hydroxyglutaric aciduria","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0007258","is_excluded":false,"label":"Severe demyelination of the white matter","onset_id":null,"reference":"OMIM:236792","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10472\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009370\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0010472</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>L-2-hydroxyglutaric aciduria is an inherited metabolic condition that is associated with progressive brain damage. Signs and symptoms of this condition typically begin during infancy or early childhood and may include developmental delay, seizures, speech difficulties, macrocephaly and abnormalities in a part of the brain called the cerebellum, which is involved in coordinating movement (i.e. balance and muscle coordination). L-2-hydroxyglutaric aciduria is caused by changes in the L2HGDH gene and is inherited in an autosomal recessive manner.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/10472\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"l-2-hydroxyglutaric-aciduria","sourceDocuments":[{"name":"GARD: L-2-hydroxyglutaric aciduria","reviewed":null,"source_release":"2026-10-25T03:41:08Z","url":"https://rarediseases.info.nih.gov/diseases/10472"},{"name":"MONDO: L-2-hydroxyglutaric aciduria","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009370"}],"sourceNote":"","synonyms":["L-2-HGA","L-2-hydroxyglutaric acidemia","L-2-hydroxyglutaric aciduria","L2HGA"],"takeawayHtml":"","title":"L-2-hydroxyglutaric aciduria"},"schemaVersion":1}
